Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000919574-25-001773·Casdin Capital, LLC
Schedule 13D ownership disclosure
Standard BioTools Inc
Common Stock, par value $0.001 per share · CUSIP: 34385P108
Event date: 2025-02-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Casdin Capital, LLCReported CIK 0001534261
Shares: 76,075,636.00 · Class: 20.4%
- Casdin Private Growth Equity Fund II, L.P.Reported CIK 0001891102
Shares: 13,939,637.00 · Class: 3.7%
- Casdin Private Growth Equity Fund II GP, LLCReported CIK 0001919480
Shares: 13,939,637.00 · Class: 3.7%
- Casdin Partners Master Fund, L.P.Reported CIK 0001534265
Shares: 59,391,780.00 · Class: 15.9%
- Casdin Partners GP, LLCReported CIK 0001534260
Shares: 59,391,780.00 · Class: 15.9%
- Eli CasdinReported CIK 0001534264
Shares: 80,864,315.00 · Class: 21.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-001773
- Form type
- SCHEDULE 13D/A
- Filer
- Casdin Capital, LLC
- CIK
- CIK 1534261
- Filed
- Mar 04, 2025
- Reporting period
- Feb 28, 2025
- Description
- Schedule 13D beneficial ownership